FindTrial
Sign In

Utility of labile form of HbA1c in monitoring of patients with diabetes mellitus

Exploring utility of Labile Glycated Hemoglobin in diabetic management: A comparative analysis with person s glycemic status. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/03/082501
Enrollment
1000
Registered
2025-03-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z000- Encounter for general adult medical examination

Interventions

Control Intervention1: Labile HbA1c, Random Blood Glucose: Labile HbA1c values generated from HPLC based A1c analysis and Random Blood Glucose values will be analysed for correlation.

Sponsors

All India Institute of Medical Sciences, Rajkot
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Laboratory data of a total of 1000 patients attending out-patient department of AIIMS, Rajkot who are prescribed with HbA1c and random plasma glucose investigations will be included, irrespective of illness and ongoing treatment.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Correlation between random blood glucose and Labile HbA1c valuesTimepoint: 3 months—

Secondary

MeasureTime frame
Variation in Stable and Labile HbA1c level in case of any hemoglobinopathies.Timepoint: 3 months—

Countries

India

Contacts

Public ContactNavya Gupta

All India Institute of Medical Sciences, Rajkot

navyaguptakg@gmail.com7014021055

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026